Redx Pharma Plc (REDX)

London
61.00
0.00(0.00%)
  • Volume:
    31,179
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    61.00 - 61.00
Unusual trading volume

Redx Pharma Plc has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

REDX Overview

Prev. Close
61
Day's Range
61-61
Revenue
16.29M
Open
61
52 wk Range
53-90
EPS
-0.068
Volume
31,179
Market Cap
203.35M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
8,234
P/E Ratio
-9.81
Beta
0.141
1-Year Change
-2.4%
Shares Outstanding
333,353,161
Next Earnings Date
-
What is your sentiment on Redx Pharma Plc?
or
Market is currently closed. Voting is open during market hours.

Redx Pharma Plc Company Profile

Redx Pharma Plc Company Profile

Employees
71

Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor for the treatment of fibrotic diseases. In addition, it develops gastrointestinal targeted ROCK inhibitor to treat crohn’s disease-associated fibrosis; discoidin domain receptors (DDRs) inhibitor for the treatment of multiple fibrotic conditions; and RXC006, a porcupine inhibitor targeting fibrotic diseases, including idiopathic pulmonary fibrosis. The company has a research collaboration agreement with Jazz Pharmaceuticals plc to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase pathway. Redx Pharma Plc was incorporated in 2010 and is based in Macclesfield, the United Kingdom.

Read More

Analyst Price Target

Average155.00 (+154.10% Upside)
High155
Low155
Price61
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsBuyStrong BuyBuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral